[Behandlung der refraktären solaren Urtikaria: Könnte Dupilumab die derzeitige Lücke schließen?]
J Dtsch Dermatol Ges
.
2023 Jun;21(6):652-654.
doi: 10.1111/ddg.15025_g.
[Article in German]
Authors
Francisco José Navarro-Triviño
1
,
Alvaro Prados-Carmona
2
,
José Aguilera
3
,
Maria Victoria de Gálvez
3
,
Ricardo Ruiz-Villaverde
2
Affiliations
1
Contact Eczema and Immunoallergic Diseases, Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
2
Dermatology Department, Hospital Universitario San Cecilio, Granada, Spain.
3
Dermatological Photobiology and Cutaneous Oncology Unit, Department of Dermatology and Medicine, University of Malaga, Malaga, Spain.
PMID:
37338841
DOI:
10.1111/ddg.15025_g
No abstract available
Publication types
Letter
Comment